Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2025-12-25 @ 2:14 AM
NCT ID:
NCT06782360
Eligibility Criteria:
Inclusion Criteria:
* Healthy human subjects between the ages of 18 and 55
* Normal color vision and near visual acuity of 20/30 without correction.
* Participant is right-hand dominant
* Proficient in the English language
* Ability to understand the explanations and instructions given by the study personnel
Exclusion Criteria:
* Participant presents current evidence of an uncontrolled and/or clinically significant medical condition or psychiatric condition
* Participant is participating in another interventional trial within 90 days prior to or throughout duration of trial
* Participant has a prior diagnosis of post-traumatic stress disorder, acute stress disorder, or generalized anxiety disorder
* Participant has a diagnosis of attention deficit hyperactivity disorder (ADHD) and/or is currently taking medications for the treatment of ADHD.
* Current or recent history of substance abuse or drug dependence including nicotine and alcohol, or use of mind-altering drugs in the past 30 days.
* Participant has abnormal ear anatomy, ear infection present, or ear piercing that could interfere with stimulation
* Participant has a recent history of epileptic seizures; including photosensitive epilepsy
* Participant has a recent history of neurologic diseases or traumatic brain injury
* Participant has presence of implanted medical devices (e.g., pacemakers, cochlear prostheses, neurostimulators)
* Females who are pregnant or lactating
* Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants are risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial
* Sensitivity to bright screens or virtual reality displays
* Recent history of neurological and psychiatric disease/disorder
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06782360
Study Brief:
Protocol Section:
NCT06782360